INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Russell Investments Group, Ltd.'s Holding History (CIK: 0001692234)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 61,075 Value ($000) $675 Avg Close — Range —
Q1 2023
Shares 73,806 Value ($000) $991 Avg Close — Range —
Q4 2022
Shares 61,668 Value ($000) $763 Avg Close — Range —
Q3 2022
Shares 54,603 Value ($000) $760 Avg Close — Range —
Q2 2022
Shares 48,886 Value ($000) $674 Avg Close — Range —
Q1 2022
Shares 53,385 Value ($000) $867 Avg Close — Range —
Q4 2021
Shares 68,845 Value ($000) $1,120 Avg Close — Range —
Q3 2021
Shares 77,037 Value ($000) $1,143 Avg Close — Range —
Q2 2021
Shares 79,483 Value ($000) $1,587 Avg Close — Range —
Q1 2021
Shares 50,206 Value ($000) $1,157 Avg Close — Range —
Q4 2020
Shares 121,441 Value ($000) $2,998 Avg Close — Range —
Q3 2020
Shares 184,213 Value ($000) $7,639 Avg Close — Range —
Q2 2020
Shares 41,903 Value ($000) $2,006 Avg Close — Range —
Q1 2020
Shares 19,860 Value ($000) $1,249 Avg Close — Range —
Q4 2019
Shares 20,561 Value ($000) $2,546 Avg Close — Range —
Q3 2019
Shares 18,154 Value ($000) $1,204 Avg Close — Range —
Q4 2017
Shares 30 Value ($000) $2 Avg Close — Range —
Q3 2017
Shares 30 Value ($000) $2 Avg Close — Range —
Q2 2017
Shares 14,092 Value ($000) $1,706 Avg Close — Range —
Q1 2017
Shares 14,683 Value ($000) $1,661 Avg Close — Range —
Q4 2016
Shares 13,083 Value ($000) $1,429 Avg Close — Range —